A recent large clinical study led by Lund University (Sweden) on multiple cohorts from Sweden, Finland, UK, Italy, Denmark, the Netherlands, USA and Germany have identified follistatin, a protein in the blood circulation, as a novel blood biomarker for the early prediction of Type 2 diabetes up to 19 years before diabetes onset.
Lundoch Diagnostics has developed an artificial intelligence (AI)-based computer program (LDT2D v. 210328) for individualized Type 2 diabetes prediction and risk assessment. By imputing patented blood biomarker measurements, the program predicts Type 2 diabetes 4 years or longer before diabetes onset.
Copyright © 2022 Lundoch - All Rights Reserved.